SEC Form 4 · accession 0001493152-26-035982
Palomino Laboratories Inc. · PALX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Ogawa
Officer — Secretary · Director
Period of report
Jul 31, 2026
Accepted (ET)
Aug 4, 2026 · 3:50 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001938569
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 31, 2026 | J | 120,000 | $5.14 | A | 1,882,500 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Pursuant to the terms of a certain Share Exchange Agreement and Plan of Reorganization, dated as of July 31, 2026, by and among Palomino Laboratories Inc. (the "Purchaser"), Vega Links, Inc. ("VLI") and the stockholders as listed on Schedule A attached thereto (the "Stockholders"), the Stockholders, who directly owned one hundred percent (100%) of the shares of VLI (the "Shares"), sold all the Shares to the Purchaser in exchange for 4,472,000 shares of the common stock, par value $0.0001 per share of the Purchaser ("Purchaser Stock"). As part of this transaction, Richard Ogawa, as a shareholder of VLI, received 120,000 shares of Purchaser Stock in exchange for his 300,000 shares of VLI.